Genetic Screening: Making better CRISPR libraries

  1. Shiyou Zhu
  2. Wensheng Wei  Is a corresponding author
  1. School of Life Sciences, Peking University, China
  2. Peking University, China

Since the human genome sequence was completed in 2003, genome-wide screening has become a popular method for quickly associating specific genes with their roles in cells. More recently, the CRISPR-Cas9 system has become the dominant tool for genome-editing (Jinek et al., 2012; Cong et al., 2013; Mali et al., 2013) and it has subsequently been adapted to make highly effective genetic screening platforms (Shalem et al., 2014; Zhou et al., 2014).

The CRISPR-Cas9 system is derived from the methods used by certain bacteria to identify and cut up foreign genetic material (Barrangou et al., 2007). To edit the genome, specially designed RNA molecules guide a nuclease enzyme called Cas9 to the location of interest in the DNA sequence; the Cas9 enzyme then cuts the DNA at this position. A mutant form of Cas9 that is unable to cut DNA can also be used to generate libraries of single guide RNAs (sgRNAs) that target regions around transcription start sites in the genome. By allowing researchers to either repress or activate gene expression – techniques that are known as CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa), respectively – these sgRNAs make it possible to carry out powerful genetic screens in mammalian cells (Gilbert et al., 2014; Konermann et al., 2015). Now, in eLife, Jonathan Weissman and colleagues at the University of California, San Francisco – including Max Horlbeck as first author – report that a new algorithm can predict the activity of sgRNAs more accurately than existing algorithms (Horlbeck et al., 2016a).

Many factors affect the ability of sgRNAs to activate or repress genes including the sequence, length and secondary structure of the sgRNA (Doench et al., 2014; Xu et al., 2015). Furthermore, the DNA in mammalian cells (and also in other eukaryotic cells) is packaged inside structures called nucleosomes, which make it difficult for the Cas9 enzyme to access the DNA (Hinz et al., 2015; Horlbeck et al., 2016b; Isaac et al., 2016). This is particularly important for CRISPRi and CRISPRa screens because the mutant Cas9 enzyme must stay bound to the DNA for extended periods of time. Horlbeck et al. therefore optimized the design of their sgRNAs to target DNA regions that were not packaged in nucleosomes and thus were more accessible to mutant Cas9.

To improve the CRISPRi and CRISPRa libraries that they had made previously (Gilbert et al., 2014), Horlbeck et al. analyzed data from 30 CRISPRi screens and 9 CRISPRa screens and defined “activity scores” for every sgRNA relative to the sgRNA with the strongest activity for each gene. They then used this information to make new CRISPRi and CRISPRa libraries that contained the ten most active sgRNAs for each gene.

The new human CRISPRi library was used to screen chronic myeloid leukemia K562 cells to identify genes that are essential for cell growth. Impressively, this library was able to identify about 10% more essential genes compared with the original CRISPRi library (Gilbert et al., 2014). Furthermore, a half-sized version of the new human CRISPRi library (with only the top five sgRNAs per gene) performed similarly to the full-sized version. This is reassuring because smaller libraries are easier to construct and use in screens. Similarly, Horlbeck et al. also demonstrated that the new human CRISPRa library outperformed the original one.

Horlbeck et al. found that, when used with the mutant form of Cas9, none of the CRISPRi libraries had toxic side effects like those observed with other approaches that use the active enzyme (Wang et al., 2015). This makes it possible to effectively identify genes, even if they show only slight differences in expression compared to negative controls.

To summarize, this study established an effective algorithm to predict the activity of sgRNAs based on the location of nucleosomes in the genome. Horlbeck et al. used this algorithm to generate new CRISPRi and CRISPRa libraries with much improved performance in genetic screens in humans and mice. It remains to be seen if the algorithm could be used to optimize other types of CRISPR screens, especially ones that use the normal Cas9 enzyme.

References

Article and author information

Author details

  1. Shiyou Zhu

    1. Biodynamic Optical Imaging Center, State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, China
    2. Peking University-Tsinghua University-National Institute of Biological Sciences Joint Graduate Program, Peking University, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  2. Wensheng Wei

    1. Biodynamic Optical Imaging Center, State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, China
    2. Beijing Advanced Innovation Center for Genomics, Peking University, Beijing, China
    3. Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
    For correspondence
    wswei@pku.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8053-2423

Publication history

  1. Version of Record published: November 3, 2016 (version 1)

Copyright

© 2016, Zhu et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,176
    Page views
  • 446
    Downloads
  • 0
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Shiyou Zhu
  2. Wensheng Wei
(2016)
Genetic Screening: Making better CRISPR libraries
eLife 5:e21863.
https://doi.org/10.7554/eLife.21863

Further reading

    1. Chromosomes and Gene Expression
    2. Computational and Systems Biology
    Arthur L Schneider, Rita Martins-Silva ... Nuno L Barbosa-Morais
    Tools and Resources

    We herein introduce voyAGEr, an online graphical interface to explore age-related gene expression alterations in 49 human tissues. voyAGEr offers a visualisation and statistical toolkit for the finding and functional exploration of sex- and tissue-specific transcriptomic changes with age. In its conception, we developed a novel bioinformatics pipeline leveraging RNA sequencing data, from the GTEx project, encompassing more than 900 individuals. voyAGEr reveals transcriptomic signatures of the known asynchronous ageing between tissues, allowing the observation of tissue-specific age periods of major transcriptional changes, associated with alterations in different biological pathways, cellular composition, and disease conditions. Notably, voyAGEr was created to assist researchers with no expertise in bioinformatics, providing a supportive framework for elaborating, testing and refining their hypotheses on the molecular nature of human ageing and its association with pathologies, thereby also aiding in the discovery of novel therapeutic targets. voyAGEr is freely available at https://compbio.imm.medicina.ulisboa.pt/app/voyAGEr.

    1. Cancer Biology
    2. Computational and Systems Biology
    Bingrui Li, Fernanda G Kugeratski, Raghu Kalluri
    Research Article

    Non-invasive early cancer diagnosis remains challenging due to the low sensitivity and specificity of current diagnostic approaches. Exosomes are membrane-bound nanovesicles secreted by all cells that contain DNA, RNA, and proteins that are representative of the parent cells. This property, along with the abundance of exosomes in biological fluids makes them compelling candidates as biomarkers. However, a rapid and flexible exosome-based diagnostic method to distinguish human cancers across cancer types in diverse biological fluids is yet to be defined. Here, we describe a novel machine learning-based computational method to distinguish cancers using a panel of proteins associated with exosomes. Employing datasets of exosome proteins from human cell lines, tissue, plasma, serum, and urine samples from a variety of cancers, we identify Clathrin Heavy Chain (CLTC), Ezrin, (EZR), Talin-1 (TLN1), Adenylyl cyclase-associated protein 1 (CAP1), and Moesin (MSN) as highly abundant universal biomarkers for exosomes and define three panels of pan-cancer exosome proteins that distinguish cancer exosomes from other exosomes and aid in classifying cancer subtypes employing random forest models. All the models using proteins from plasma, serum, or urine-derived exosomes yield AUROC scores higher than 0.91 and demonstrate superior performance compared to Support Vector Machine, K Nearest Neighbor Classifier and Gaussian Naive Bayes. This study provides a reliable protein biomarker signature associated with cancer exosomes with scalable machine learning capability for a sensitive and specific non-invasive method of cancer diagnosis.